https://www.selleckchem.com/pr....oducts/dss-crosslink
alone. To establish the feasibility of a definitive randomised controlled trial of Systemic Autism-related Family Enabling (SAFE), an intervention for families of children with autism. A randomised, controlled, multicentred feasibility study. Participants were identified from three National Health Service (NHS) diagnosing centres in Plymouth and Cornwall and a community pathway. 34 families of a child with a diagnosis of autism severity level 1 or 2 between 3 and 16 years. Four families were lost to follow-up. SAFE is a manualis